Cargando…
Venous thromboembolism and cancer risk
Cancer increases the risk of venous thromboembolism (VTE) and about 20 % of all VTE are associated with cancer. VTE can also be used as a marker for occult cancer. The objective was to examine the correlation between VTE and cancer regarding predictors for a subsequent cancer diagnosis. Patients tre...
Autores principales: | Sandén, Per, Svensson, Peter J., Själander, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233740/ https://www.ncbi.nlm.nih.gov/pubmed/27522504 http://dx.doi.org/10.1007/s11239-016-1411-y |
Ejemplares similares
-
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020) -
Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome—A retrospective observational study
por: Welander, Frida, et al.
Publicado: (2021) -
Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model
por: Ahmad, Abrar, et al.
Publicado: (2018) -
Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study
por: Salim, Saman, et al.
Publicado: (2019) -
Pharmacological cancer treatment and venous thromboembolism risk
por: Muñoz Martín, Andrés J, et al.
Publicado: (2020)